Wolverine Blend

Description

This dual-peptide formulation combines the two most extensively researched compounds for musculoskeletal recovery: BPC-157 (Body Protection Compound) and TB-500 (Synthetic Thymosin Beta-4 Fragment).

Researchers utilize this “stack” to investigate the powerful synergy between angiogenesis (promoted by BPC-157) and cell migration (promoted by TB-500). While BPC-157 acts primarily by upregulating VEGF receptors to create new vascular pathways for nutrient delivery, TB-500 acts by sequestering actin, a protein essential for the mobility of repair cells. Together, they create a comprehensive research model for accelerated tissue repair that addresses both the “supply line” (blood flow) and the “workforce” (cellular movement).

Key Research Applications

• Accelerated Soft Tissue Repair: This blend is the industry standard for researching tendon, ligament, and muscle tears. The combination is investigated for its ability to reduce the time-to-heal in rat Achilles tendon models by simultaneously reducing inflammation and increasing the tensile strength of the remodeling tissue.

• Synergistic Mechanism: Studies suggest that BPC-157 increases the expression of growth hormone receptors in fibroblasts, while TB-500 facilitates the migration of those fibroblasts to the site of injury. This “one-two punch” is researched for its potential to prevent scar tissue formation (fibrosis) while speeding up recovery.

• Systemic Cytoprotection: Beyond local injury, the blend is studied for systemic protective effects, including gastrointestinal integrity (via BPC-157) and cardiac tissue preservation following ischemic events (via TB-500).

⚠️ FOR RESEARCH PURPOSES ONLY This product is intended for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic use. Handle with care and adhere to all laboratory safety protocols.